Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5

被引:10
作者
Zombori, Tamas [1 ]
Cserni, Gabor [1 ,2 ]
机构
[1] Univ Szeged, Dept Pathol, Fac Med, Allomas U 1, H-6725 Szeged, Hungary
[2] Bacs Kiskun Cty Teaching Hosp, Dept Pathol, Kecskemet, Hungary
关键词
Basal-like; Triple negative breast cancer; GATA-3; Mammaglobin; GCDFP-15; NY-BR-1; DISEASE FLUID PROTEIN-15; DIFFERENTIATION ANTIGEN NY-BR-1; UTEROGLOBIN GENE FAMILY; FEMALE GENITAL-TRACT; GATA3; IMMUNOHISTOCHEMISTRY; ESTROGEN-RECEPTOR; CLINICOPATHOLOGICAL ANALYSIS; MAMMAGLOBIN EXPRESSION; DIAGNOSTIC UTILITY; IDENTIFICATION;
D O I
10.1007/s12253-017-0246-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Estrogen and progesterone receptors are possible markers for suggesting a mammary origin of metastatic carcinoma, but are useless in cases of triple negative breast cancers (TNBC). Five other potential markers of breast origin were investigated on tissue microarrays in a series of TNBCs showing keratin 5 expression, consistent with a basal-like phenotype. GATA-3 staining was observed in 82 of 115 triple negative cases (71.3%) including 23 cases with > 5% staining. Mammaglobin staining was detected in 30 cases (26.0%) including 12 with > 5% staining. GCDFP-15 was seen in 23 cases (20.0%) including 9 with > 5% staining. NY-BR-1 positivity was present in 7 cases (6.0%) including 3 patients with > 5% staining. BCA-225 staining was observed in 74 cases (64.3%); however this latter marker lacks also specificity owing to the reported widespread staining in other malignancies. GATA-3, mammaglobin and GCDFP-15 coexpression was seen in one case (0.9%), whereas GATA-3 and mammaglobin or mammaglobin and GCDFP-15 coexpression was present in 2 and 2 cases (1.7%), respectively. Using at least 5% staining as cut-off, the expression of any of the last 4 markers was 34.7%. The expression of GATA-3, mammaglobin, GCDFP-15 and NY-BR-1 is lower in TNBC-s than in breast carcinomas in general, and this may be even lower in basal-like carcinomas. Although these markers are not fully specific, by using them, a subset of basal-like TNBC-s can be identified as of mammary origin. However, a substantial proportion will not show any staining with any of these markers.
引用
收藏
页码:259 / 267
页数:9
相关论文
共 50 条
  • [31] Triple-negative breast cancer and basal-like subtype : Pathology and targeted therapy
    Bando, Yoshimi
    Kobayashi, Tomoko
    Miyakami, Yuko
    Sumida, Satoshi
    Kakimoto, Takumi
    Saijo, Yasuyo
    Uehara, Hisanori
    JOURNAL OF MEDICAL INVESTIGATION, 2021, 68 (3-4) : 213 - 219
  • [32] Immunohistochemical Evaluation of GATA-3 Expression in ER-Negative Breast Carcinomas
    Liu, Haiyan
    Shi, Jianhui
    Prichard, Jeffrey W.
    Gong, Yun
    Lin, Fan
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2014, 141 (05) : 648 - 655
  • [33] Expression of Tight Junction Protein Claudin-4 in Basal-Like Breast Carcinomas
    Kulka, Janina
    Szasz, Attila Marcell
    Nemeth, Zsuzsanna
    Madaras, Lilla
    Schaff, Zsuzsa
    Molnar, Istvan Arthur
    Tokes, Anna-Maria
    PATHOLOGY & ONCOLOGY RESEARCH, 2009, 15 (01) : 59 - 64
  • [34] Modulatory Role of microRNAs in Triple Negative Breast Cancer with Basal-Like Phenotype
    Angius, Andrea
    Cossu-Rocca, Paolo
    Arru, Caterina
    Muroni, Maria Rosaria
    Rallo, Vincenzo
    Carru, Ciriaco
    Uva, Paolo
    Pira, Giovanna
    Orru, Sandra
    De Miglio, Maria Rosaria
    CANCERS, 2020, 12 (11) : 1 - 29
  • [35] The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge
    Temian, Daiana Cosmina
    Pop, Laura Ancuta
    Irimie, Alexandra Iulia
    Berindan-Neagoe, Ioana
    JOURNAL OF BREAST CANCER, 2018, 21 (03) : 233 - +
  • [36] Hippo-TAZ signaling is the master regulator of the onset of triple-negative basal-like breast cancers
    Soyama, Hirotoshi
    Nishio, Miki
    Otani, Junji
    Sakuma, Toshiko
    Takao, Shintaro
    Hara, Shigeo
    Masuda, Takaaki
    Mimori, Koshi
    Toyokuni, Shinya
    Lydon, John P.
    Nakao, Kazuwa
    Nishina, Hiroshi
    Fukumoto, Takumi
    Maehama, Tomohiko
    Suzuki, Akira
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2022, 119 (29)
  • [37] Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
    Prat, Aleix
    Adamo, Barbara
    Cheang, Maggie C. U.
    Anders, Carey K.
    Carey, Lisa A.
    Perou, Charles M.
    ONCOLOGIST, 2013, 18 (02) : 123 - 133
  • [38] TRPS1 expression in cytokeratin 5 expressing triple negative breast cancers, its value as a marker of breast origin
    Szintia Almási
    Levente Kuthi
    Anita Sejben
    András Vörös
    Ákos Nagy
    Tamás Zombori
    Gábor Cserni
    Virchows Archiv, 2023, 482 : 861 - 868
  • [39] Clinical significance of basal-like subtype in triple-negative breast cancer
    Yamamoto, Yutaka
    Ibusuki, Mutsuko
    Nakano, Masahiro
    Kawasoe, Teru
    Hiki, Ryousuke
    Iwase, Hirotaka
    BREAST CANCER, 2009, 16 (04) : 260 - 267
  • [40] Modeling vitamin D actions in triple negative/basal-like breast cancer
    LaPorta, Erika
    Welsh, JoEllen
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2014, 144 : 65 - 73